Nhs_choices Bthft Bradford Teaching HospitalsNHS Foundation Trust NHS Choices
  • Text Size

  • Language

    loading

10 - Musculo-skeletal

NICE Technologies Applicable to this BNF Section
TA Number TA Subject Has the recommendation in the TA been implemented in the organisation for example by changes to the local formulary for drugs, procurement of devices or changes to care pathways? (Yes/No/TA Not Applicable to this organisation)
TA302 Juvenile idiopathic arthritis (systemic) - canakinumab (terminated apprasaisal)(TA302) Yes
TA291 Gout (tophaceous, severe debilitating, chronic) - pegloticase (TA291) Yes
TA281 Gout - canakinumab (terminated appraisal)(TA281) Yes
TA280 Rheumatois arthritis - abatacept (2nd line)(rapid review of TA234)(TA280) Yes
TA247 Rheumatoid arthritis - tocilizumab (rapid review TA198) (TA247) Yes
TA238 Arthritis (juvenile idiopathic, systemic) - tocilizumab (TA238) Yes
TA234 Rheumatoid arthritis - abatacept (2nd line) (TA234) Yes
TA233 Ankylosing spondiylitis - golimumab (TA233) Yes
TA225 Rheumatoid arthritis (after the failure of previous anti-rheumatic drugs) - golimumab (TA225) Yes
TA224 Rheumatoid arthritis (methotrexate naive) - golimumab (terminated appraisal (TA224) Yes
TA220 Psoriatic arthritis - golimumab (TA220) Yes
TA199 Psoriatic arthritis - etanercept, infliximab and adalimumab (TA199) Yes
TA195 Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor (TA195) Yes
TA186 Rheumatoid arthritis - certolizumab pegol (TA186) Yes
TA164 Hyperuricaemia - febuxostat (TA164) Yes
TA143 Ankylosing spondylitis - adalimumab, etanercept and infliximab (TA143) Yes
TA130 Rheumatoid arthritis - adalimumab, etanercept and infliximab (TA130) Yes
TA89 Cartilage injury - autologous chondrocyte implantation (ACI) for the treatment of cartilage injury (review of exisitng guidance TA16) (TA89) Yes
TA44 Hip disease - metal on metal resurfacing (TA44) Yes
TA35
Arthritis (juvenile idiopathic) - etanercept (TA35)
Yes
TA2
Hip disease - replacement prostheses (TA2)
Yes